Junevity
San Francisco, California, United States · Biotechnology, Genetics, Health Care
Junevity is a longevity biotechnology company developing Cell Reset therapeutics. The RESET Platform is the first to use large-scale human data and AI to develop novel siRNA therapeutics targeting transcription factors. Founded out of UCSF in 2023, Junevity’s mission is to extend human lifespan and healthspan.
Key facts
- Headquarters
- San Francisco, California, United States
- Employees
- 13
- Industries
- Biotechnology, Genetics, Health Care
- Status
- Private
- Website
- junevity.com
- Company page
Recent activity at Junevity
Junevity funding history
| Date | Round | Amount |
|---|---|---|
| Feb 2025 | Seed | $10.0M |
Leadership
- Rob Cahill, Co-founder, Chief Operating and Business Officer
- Janine Sengstack, Founder
- John Hoekman, Chief Executive Officer
Verified email and direct lines for Junevity’s decision-makers are on Fundz. See plans
Junevity in the news
- Junevity takes gene-network reset into skincare - Longevity.Technology (Sep 29, 2026)
- Amorepacific and Junevity Partner to Develop Next-Generation Products for Skin Rejuvenation - Yahoo Finance (Sep 29, 2026)
- Amorepacific Invests in Junevity to Develop Next-Generation Skin Rejuvenation Technology - Global Cosmetics News (Oct 01, 2026)
- Junevity to Present Breakthrough Research on siRNA Therapeutics at American Aging Association’s 2026 Annual Meeting - businesswire.com (May 27, 2026)
- Junevity Announces First Peer-Reviewed Research Showing Single-Target Repression Can Reprogram Cellular Aging - CRISPR Medicine News (Jan 12, 2026)
- Junevity Partners with Sunrise BioVentures as Advisors to Accelerate siRNA Therapeutic Development - Yahoo Finance (Jun 10, 2026)
- Juvenity - Lifespan Research Institute (Jan 04, 2026)
- Junevity Expands Seed Funding to $20 Million for Cell Reprogramming with siRNA - BioSpace (Dec 03, 2025)
Companies similar to Junevity
- Aurora Therapeutics · Biotechnology, Genetics, Health Care, Therapeutics
- Exegenesis Bio · Biotechnology, Genetics, Health Care, Therapeutics
- Aptadir Therapeutics · Biotechnology, Genetics, Health Care, Therapeutics
- MeiraGTx Holdings plc · Biotechnology, Genetics, Health Care, Therapeutics
- Gaomei Gene · Biotechnology, Genetics, Health Care, Therapeutics
About Junevity: questions and answers
What does Junevity do?
Junevity is a longevity biotechnology company developing Cell Reset therapeutics. The RESET Platform is the first to use large-scale human data and AI to develop novel siRNA therapeutics targeting transcription factors. Founded out of UCSF in 2023, Junevity’s mission is to extend human lifespan and healthspan.
Where is Junevity headquartered?
Junevity is headquartered in San Francisco, California, United States.
How many employees does Junevity have?
Junevity has about 13 employees.
Has Junevity raised funding?
Yes. Fundz has recorded 1 funding event for Junevity. The most recent, Seed of $10.0M, was in Feb 2025.
Who leads Junevity?
Rob Cahill is a Co-founder, Chief Operating and Business Officer at Junevity.
What is the latest news on Junevity?
On Feb 13, 2025, Junevity raised $10M in seed funding led by Goldcrest Capital and Godfrey Capital to enhance its RESET platform for developing cell reset therapeutics for longevity.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy